Hong Kong's first five-year plan to feature biomedicine and GBA medical cooperation
Global pharmaceutical company GSK emphasises interest in expanding biotech role as Hong Kong prepares to unveil its first five-year plan.
Quick Look
Hong Kong's upcoming first five-year plan will feature biomedicine, aiming to boost medical cooperation across the Greater Bay Area, as announced by Health Secretary Lo Chung-mau at BIOHK.
AI-generated summary
Why It Matters
Biomedicine has been designated as a strategic emerging industry in national blueprints.
Biomedicine is set to feature in Hong Kong’s first five-year plan, due to be unveiled next week, as the city’s top officials signal closer medical cooperation across the Greater Bay Area.
Lending weight to those ambitions, global pharmaceutical company GSK emphasised its interest in expanding its role in the region’s biotech development on Wednesday, at the fifth Hong Kong International Biotechnology Conference and Exhibition (BIOHK).
Speaking at the event, Hong Kong Secretary for Health Lo Chung-mau said the city’s first five-year plan would align with the national blueprint, which had designated biomedicine as “one of the emerging industries of strategic importance”.
“Biotechnology is ... a national and regional imperative. And Hong Kong is answering that call with conviction and speed,” Lo said.
The city, he noted, served as a “superconnector” and “super value-added” hub for biotech and manufacturing capacity in the Greater Bay Area – the integrated economic and business hub linking Hong Kong and Macau with cities in Guangdong province.
The region, home to 88 million people, generated a gross domestic product of more than 15 trillion yuan (US$2.23 trillion) in 2025, official data showed.
Hong Kong’s first-ever five-year plan is expected to be unveiled on September 16 at a Legislative Council meeting, followed by Chief Executive John Lee Ka-chiu’s 2026 policy address.
What to Watch
AI outlook — possibilities, not facts
Hong Kong's first five-year plan will be unveiled at a Legislative Council meeting
Very likely · Within days
Open Questions
- What specific funding will be allocated in the five-year plan?
- How will cross-border regulatory hurdles be addressed?




